Form 4 for INBX Inhibrx Biosciences, Inc.
Accepted 2024-10-07 00:00:00 ET · period of report 2024-10-03 · accession 0002007919-24-000051 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-07 | 2024-10-03 | INBX | Vuori Kristiina MD | Dir | P - Purchase | $15.00 | +6,667 | 20.4K | +48% | +$100.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-03 | P | A | 6,667 | $15.00 | 20,443 | D | — | — |